BMJ open · 2026
Strategies to increase medications for opioid use disorder in hospital settings in the USA: protocol for a scoping review.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hoemann Benjamin, Lane Alex, Laine Randy O, Shy Corey, Moller Alyssa, Marks Laura, Hartz Sarah M, Hardi Angela, Ramsey Alex, Li Jing
Аннотация
INTRODUCTION: Opioid use disorder (OUD) remains a serious and life-threatening disease. Medications for opioid use disorder (MOUD) are effective treatments for OUD but a minority of eligible patients receive them. Hospitalisation is an opportune time to increase MOUD use. However, the description of the most successful strategies to implement MOUD is underexplored. This scoping review will methodically review what strategies have been described in the literature to increase MOUD use in hospital settings in the USA.
METHODS AND ANALYSIS: Our scoping review will be completed using methods outlined by the JBI Manual for Evidence Synthesis. English-language studies published after 1 January 2000, and situated in the USA will be included. Studies must explicitly mention an implementation strategy with the aim to increase MOUD initiation in a hospital setting. MOUD will include buprenorphine, methadone and naltrexone. Experimental and observational studies will be included for review. Our search strategy will be guided by an academic librarian to search Ovid-Medline, Embase, CINAHL, APA PsycInfo, Scopus, Web of Science and Sociological Abstracts for peer-reviewed studies from 1 January 2000 to present. Studies will be described by their strategy components, potential mechanisms and outcomes. We will report our findings according to the Preferred Reporting Items for Systematic reviews and Meta-Analysis Extension for Scoping Reviews. Study selection and data extraction will be completed by two reviewers. If disagreements arise, the study will be reviewed and resolved by a third reviewer.
ETHICS AND DISSEMINATION: This study does not involve the collection of new data and therefore does not require approval from an institutional review board. We will submit the results of our review to an academic peer-reviewed journal for publication and to relevant stakeholders.
METHODS AND ANALYSIS: Our scoping review will be completed using methods outlined by the JBI Manual for Evidence Synthesis. English-language studies published after 1 January 2000, and situated in the USA will be included. Studies must explicitly mention an implementation strategy with the aim to increase MOUD initiation in a hospital setting. MOUD will include buprenorphine, methadone and naltrexone. Experimental and observational studies will be included for review. Our search strategy will be guided by an academic librarian to search Ovid-Medline, Embase, CINAHL, APA PsycInfo, Scopus, Web of Science and Sociological Abstracts for peer-reviewed studies from 1 January 2000 to present. Studies will be described by their strategy components, potential mechanisms and outcomes. We will report our findings according to the Preferred Reporting Items for Systematic reviews and Meta-Analysis Extension for Scoping Reviews. Study selection and data extraction will be completed by two reviewers. If disagreements arise, the study will be reviewed and resolved by a third reviewer.
ETHICS AND DISSEMINATION: This study does not involve the collection of new data and therefore does not require approval from an institutional review board. We will submit the results of our review to an academic peer-reviewed journal for publication and to relevant stakeholders.